{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:09:45Z","timestamp":1747159785965,"version":"3.40.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fundaci\u00f3n Navarro Tripodi"},{"name":"Proyecto Bancaja-UMH"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejps.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T11:13:00Z","timestamp":1522840380000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats"],"prefix":"10.1016","volume":"119","author":[{"given":"M.I.","family":"Mas-Fuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ramon-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Lacueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"M\u00e1s-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-6372","authenticated-orcid":false,"given":"R.","family":"Nalda-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejps.2018.04.004_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00001813-200311000-00007","article-title":"Population pharmacokinetics of oxaliplatin in patients with metastatic cancer","volume":"14","author":"Bastian","year":"2003","journal-title":"Anti-Cancer Drugs"},{"year":"2009","author":"Beal","series-title":"NONMEM User's Guides. (1989\u20132009), Icon Development Solutions, Ellicott City, MD, USA","key":"10.1016\/j.ejps.2018.04.004_bb0010"},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0015","first-page":"BR1","article-title":"A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat","volume":"11","author":"Bendavid","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejps.2018.04.004_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.ejps.2018.04.004_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-8-7","article-title":"Long-term platinum retention after treatment with cisplatin and oxaliplatin","volume":"17","author":"Brouwers","year":"2008","journal-title":"BMC Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2018.04.004_bb0030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejso.2015.08.174","article-title":"HIPEC and nephrotoxicity: a cisplatin induced effect?","volume":"42","author":"Ceresoli","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ejps.2018.04.004_bb0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-014-2525-6","volume":"74","author":"Chalret du Rieu","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"41","key":"10.1016\/j.ejps.2018.04.004_bb0040","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0045","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3747\/co.22.2058","article-title":"Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms","volume":"22","author":"Dub\u00e9","year":"2015","journal-title":"Curr. Oncol."},{"year":"1993","author":"Efron","series-title":"An Introduction to the Bootstrap","key":"10.1016\/j.ejps.2018.04.004_bb0050"},{"key":"10.1016\/j.ejps.2018.04.004_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","article-title":"Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution","volume":"13","author":"Elias","year":"2002","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ejps.2018.04.004_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/ASO.2004.09.008","article-title":"Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials","volume":"11","author":"Elias","year":"2004","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ejps.2018.04.004_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejso.2006.03.004","article-title":"Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: pharmacologic studies","volume":"32","author":"Elias","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.ejps.2018.04.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002206","article-title":"An integrated disease\/pharmacokinetic\/pharmacodynamic model suggests improved Interleukin-21 regimens validated prospectively for mouse solid cancers","volume":"7","author":"Elishmereni","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0080","first-page":"154","article-title":"Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia","volume":"38","author":"Escudero-Ortiz","year":"2014","journal-title":"Farm. Hosp."},{"issue":"4","key":"10.1016\/j.ejps.2018.04.004_bb0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00280-007-0654-x","article-title":"Pharmacokinetics of heated intraperitoneal oxaliplatin","volume":"62","author":"Ferron","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0090","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1186\/1471-2407-14-807","article-title":"Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis","volume":"14","author":"Glockzin","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jso.23464","article-title":"Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models","volume":"109","author":"Gremonprez","year":"2014","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1208\/s12248-012-9324-y","article-title":"A mechanism-based approach for absorption modeling: the gastro-intestinal transit time (GITT) model","volume":"14","author":"H\u00e9nin","year":"2012","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.ejps.2018.04.004_bb0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jso.23546","article-title":"The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study","volume":"109","author":"Hompes","year":"2014","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ejps.2018.04.004_bb0120","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.bjp.0707643","article-title":"Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats","volume":"153","author":"Huntjens","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002800050721","article-title":"Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model","volume":"41","author":"Jacquet","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","article-title":"Diagnosing model diagnostics","volume":"82","author":"Karlsson","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00280-003-0626-8","article-title":"Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics","volume":"52","author":"de Lima Vazquez","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-002-0531-6","article-title":"Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat","volume":"50","author":"Liu","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0145","first-page":"1","article-title":"Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats","author":"Mas-Fuster","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000324395","article-title":"Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study","volume":"46","author":"Muller","year":"2011","journal-title":"Eur. Surg. Res."},{"issue":"3","key":"10.1016\/j.ejps.2018.04.004_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000102597","article-title":"Hyperthermia alters kidney function and renal scintigraphy","volume":"27","author":"Mustafa","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"7","key":"10.1016\/j.ejps.2018.04.004_bb0160","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1245\/s10434-010-0937-z","article-title":"Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques","volume":"17","author":"Ortega-Deballon","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-5-56","article-title":"A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis","volume":"5","author":"Pelz","year":"2005","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejps.2018.04.004_bb0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00280-012-2060-2","article-title":"Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery","volume":"71","author":"P\u00e9rez-Ruixo","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2018.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40262-013-0092-3","article-title":"Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin","volume":"52","author":"P\u00e9rez-Ruixo","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ejps.2018.04.004_bb0180","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00280-014-2436-6","article-title":"Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients","volume":"73","author":"P\u00e9rez-Ruixo","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1208\/s12248-015-9839-0","article-title":"Platelet dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin","volume":"18","author":"P\u00e9rez-Ruixo","year":"2016","journal-title":"AAPS J."},{"issue":"6","key":"10.1016\/j.ejps.2018.04.004_bb0190","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/030089169808400619","article-title":"Pharmacokinetics of intraperitoneal gemcitabine in a rat model","volume":"84","author":"Pestieau","year":"1998","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9098(200102)76:2<106::AID-JSO1020>3.0.CO;2-E","article-title":"Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies","volume":"76","author":"Pestieau","year":"2001","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Pich\u00e9","year":"2011","journal-title":"Ann. Surg."},{"year":"2016","author":"R Core Team","series-title":"R: A Language and Environment for Statistical Computing","key":"10.1016\/j.ejps.2018.04.004_bb0205"},{"key":"10.1016\/j.ejps.2018.04.004_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01212608","article-title":"Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells","volume":"123","author":"Rietbroek","year":"1997","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.ejps.2018.04.004_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"29","author":"Robella","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharmacokinet."},{"year":"2015","author":"RStudio Team","series-title":"RStudio: Integrated Development for R","key":"10.1016\/j.ejps.2018.04.004_bb0225"},{"issue":"2","key":"10.1016\/j.ejps.2018.04.004_bb0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003088-200443020-00005","article-title":"Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy","volume":"43","author":"van Ruth","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.ejps.2018.04.004_bb0235","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","article-title":"Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions","volume":"11","author":"Savic","year":"2009","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ejps.2018.04.004_bb0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","article-title":"Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies","volume":"34","author":"Savic","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2018.04.004_bb0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0749-0704(18)30550-5","article-title":"Effect of anesthesia and surgery on renal function","volume":"3","author":"Sladen","year":"1987","journal-title":"Crit. Care Clin."},{"issue":"6","key":"10.1016\/j.ejps.2018.04.004_bb0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jso.23527","article-title":"Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis","volume":"109","author":"S\u00f8rensen","year":"2014","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ejps.2018.04.004_bb0255","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","article-title":"Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ejps.2018.04.004_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CNV-50478","article-title":"Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer","volume":"23","author":"Sugarbaker","year":"2005","journal-title":"Cancer Investig."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0265","first-page":"29","article-title":"Surgical technology and pharmacology of hyperthermic perioperative chemotherapy","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0270","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4613-1247-5_26","article-title":"A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat. Res."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.004_bb0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1208\/s12248-010-9249-2","article-title":"Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis","volume":"13","author":"Valenzuela","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.04.004_bb0280","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2018.04.004_bb0285","doi-asserted-by":"crossref","DOI":"10.1208\/ps040427","article-title":"Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis","volume":"4","author":"Wahlby","year":"2002","journal-title":"AAPS PharmSci"},{"issue":"4","key":"10.1016\/j.ejps.2018.04.004_bb0290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0039-6060(96)80145-0","article-title":"Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination","volume":"119","author":"Yonemura","year":"1996","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.ejps.2018.04.004_bb0295","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1200\/JCO.1987.5.10.1613","article-title":"Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia","volume":"5","author":"Zakris","year":"1987","journal-title":"J. Clin. Oncol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T14:28:49Z","timestamp":1534948129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718301593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":59,"alternative-id":["S0928098718301593"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.004","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}